Lobbying Filing Details

Total Spending

$1,000,000

Activities

4

Lobbyists

5

Gov't Entities

10

Filing Information
Filing UUID:
8cf1a7aa-facc-4007-aa90-8455baa8a6cc
Type:
Q3 - 3rd Quarter - Report
Period:
2024 - 3rd Quarter (July 1 - Sep 30)
Date Posted:
October 18, 2024 at 8:29 PM
Income:
$0
Expenses:
$1,000,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Samantha Ventimiglia
Registrant
VERTEX PHARMACEUTICALS INCORPORATED

Global biotechnology company

Boston, Massachusetts
Client
VERTEX PHARMACEUTICALS INCORPORATED
Massachusetts, United States of America
Lobbying Activities (4)
Activity 1
Budget/Appropriations

Access to non-opioids in DoD/Tricare (H.R.8774/S.4921 - Department of Defense Appropriations Act, 2025); Access to non-opioids in VHA and general support for clinical trial operations at VHA to address high prevalence diseases and conditions (H.R.8580/S.4677 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2025); Access to non-opioids for Medicare beneficiaries and education about risk of kidney disease amongst minority populations (H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025).

Lobbyists (5)
  • MATTHEW O SCHUMAKER
  • SWARNA VALLURUPALLI
  • ERIN MENDELSOHN
  • MS. HANNAH BETH CORNWELL
  • MS. KRISTIN "SEUM" RICHTER
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Health Issues

Federal policies impacting pharmaceutical development, approval, and reimbursement; Copay accumulators and maximizers, HELP Copays Act (H.R. 830/S. 1375); Alternative Funding Programs; Unmet medical need in acute pain; Barriers to patient access of non-opioid pain medicines; Genetic kidney disease, including APOL-1; Ex-US access to innovative medicines; Cystic Fibrosis; Sickle cell disease.

Lobbyists (5)
  • MATTHEW O SCHUMAKER
  • SWARNA VALLURUPALLI
  • ERIN MENDELSOHN
  • MS. HANNAH BETH CORNWELL
  • MS. KRISTIN "SEUM" RICHTER
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Centers For Medicare and Medicaid Services (CMS)
Activity 3
Medicare/Medicaid

Unmet medical need in acute pain; H.R.7421/S.3832 - The Alternatives to PAIN Act; Implementation of Public Law No: 117-328 sec. 4135 NO PAIN Act; Medically necessary fertility treatments for patients undergoing fully myeloablative conditioning.

Lobbyists (5)
  • MATTHEW O SCHUMAKER
  • SWARNA VALLURUPALLI
  • ERIN MENDELSOHN
  • MS. HANNAH BETH CORNWELL
  • MS. KRISTIN "SEUM" RICHTER
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Centers For Medicare and Medicaid Services (CMS)
Activity 4
Taxation/Internal Revenue Code

Corporate tax reform.

Lobbyists (1)
  • SWARNA VALLURUPALLI
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.